Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

The results also compare favourably with results seen with Boehringer Ingelheim and Zealand Pharma’s dual GLP-1 and glucagon agonist survodutide, which showed weight loss of around 19% at 46 ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Coloplast A/S Series B kr.721.80 7.00 0.98% ...

It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...